Steven Cohen’s NewAmsterdam Pharma NAMS Stock Holding History
Bought
Maintained
Sold
Other funds holding NAMS
DFO
Steven Cohen's NAMS Position: Q3 2026 in Review
Steven Cohen sold out of NewAmsterdam Pharma (NAMS) in Q3 2026, closing a stake of 168,901 shares — an estimated $4.67M sold.
Steven Cohen first reported a position in NAMS in Q2 2026 and held it in 1 quarter. The position peaked at $5.72M in Q2 2026. 183 funds tracked by Wall St. Rank hold NAMS as of Q3 2026.
- Steven Cohen reported no remaining NewAmsterdam Pharma position as of Q3 2026 after selling out during the quarter.
- Steven Cohen sold 168,901 NewAmsterdam Pharma shares in Q3 2026, an estimated $4.67M.
- Steven Cohen first reported a position in NewAmsterdam Pharma in Q2 2026 and held it in 1 quarter.
- Steven Cohen's NewAmsterdam Pharma position peaked at $5.72M in Q2 2026.
- 183 funds tracked by Wall St. Rank held NewAmsterdam Pharma as of Q3 2026.
Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.